Since the immunosuppressive function of DEX acts on T cells, the percentage of CD4 T cells in the blood, spleen and pancreas of DEX treated mice were decrease compared with that in T1D control group (Figure 4). The gene discussed is CD4; the disease is type 1 diabetes mellitus.